Connect with us
Finance Digest is a leading online platform for finance and business news, providing insights on banking, finance, technology, investing,trading, insurance, fintech, and more. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.


Dialysis firm FMC sees robust 2024 earnings growth after strong Q4

GDANSK (Reuters) – Fresenius Medical Care on Tuesday forecast its core earnings to grow by a mid- to high-teens percentage this year, after the German dialysis specialist’s fourth-quarter earnings topped market expectations.

Last year, the company’s adjusted operating income increased by 15% to 1.7 billion euros ($1.83 billion).

“Based on the turnaround progress achieved last year, we have a strong foundation to build on to make 2024 a year of accelerated profitable growth,” CEO Helen Giza said.

Supported by its cost-cutting plan FME25, the German firm managed to save about 350 million euros during the year, almost 50 million euros more than initially planned.

In 2023, FMC sold 127 facilities with a headcount of more than 4,500 employees in the United States, Argentina and Australia.

FMC, which employs 120,000 people in 4,000 clinics globally, said its adjusted operating income grew 18% to 555 million euros in the October-December period, compared with a median consensus of 546 million in a poll by Vara Research.

Earnings for FMC, the world’s biggest dialysis provider, are recovering after they were hit by slower patient flows due to excess mortality rates during the pandemic.

Its turnaround plan and a 175-million-euro one-off payment related to a legal settlement in the United States also helped lift its quarterly numbers.

The company used the proceeds to reduce its net debt by 11% to 10.8 billion euros.

FMC proposed a dividend of 1.19 euros per share for 2023, representing a 6% annual increase.

Shares rose 1.3% in the Lang & Schwarz pre-market indications.

($1 = 0.9285 euros)


(Reporting by Andrey Sychev and Chiara Holzhaeuser in Gdansk; Editing by Milla Nissi and Sherry Jacob-Phillips)


Continue Reading

Why pay for news and opinions when you can get them for free?

       Subscribe for free now!

By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Posts